BRYNJELSEN SEAN 4
4 · Eton Pharmaceuticals, Inc. · Filed Aug 20, 2021
Insider Transaction Report
Form 4
BRYNJELSEN SEAN
DirectorPresident & CEO10% Owner
Transactions
- Purchase
Common Stock
2021-08-20$4.32/sh+10,000$43,200→ 1,030,000 total
Holdings
- 24,940(indirect: By LLC)
Common Stock